NASDAQ · Biotechnology
ABEO (ABEO) Stock
$7.14
+3.48%
NASDAQ: ABEO
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Jul 1, 2026
Insider Favorites: Top Growth Companies For June 2026
Simply Wall St. · Jun 10, 2026
Top Growth Companies With Insider Ownership In June 2026
Simply Wall St. · Jun 10, 2026
3 Growth Companies With High Insider Ownership Seeing Up To 94% Earnings Growth
Simply Wall St. · Jun 8, 2026
Insider Favorites High Growth Companies June 2026
Simply Wall St. · Jun 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held16.59%
Institutions Held70.37%
Institutions Float Held84.37%
Peer Comparison
About ABEO
ABEO is led by CEO Vishwas Seshadri, employs 136 people, headquartered in US, publicly traded since 1980.
ABEO stock trades at $7.14 with a market capitalization of $406.94M. The stock is valued at a price-to-earnings (P/E) ratio of 5.14, price-to-book of 1.86, price-to-sales of 20.87. Over the past 52 weeks the stock has ranged between $4.00 and $7.54, and currently trades 5.3% below its 52-week high.
On profitability, ABEO generates a return on equity (ROE) of 44.65% — well above the market average, a sign of a high-quality business, return on capital employed of -55.62%, an operating margin of -1483.33%, a net profit margin of 4.55%.